APC guidance has been grouped according to BNF chapter.
Guidance includes
– Shared care guidance
– Clinical guidelines
– Information sheets – to help ongoing care in primary care following specialist initiation/recommendation.

Gastro-Intestinal System

Abnormal LFT Guidelines NENC Hepatology Network V2.1 Sept 2020 Final
Bariatric surgery – management of patients, post-bariatric surgery, in primary care June 2021
Prescribing Trans Anal Irrigation – guidelines for prescribing 2019 v2.0

Cardiovascular System
Amiodarone SCG v1.1
Angina GL (Updated 2014)
Atrial fibrillation – Prescribing for Non-valvular AF in Primary Care v2.0
Dronedarone SCG – Sept 17
Northern England Evaluation and Lipid Intensification NEELI Clinical Guidelines (replaces FATS7)

Respiratory System
COPD management guidelines v2.0

Central Nervous system
Agomelatine – Primary Care Information Sheet v1.0
Cognitive enhancing medication – leaflet for primary care v2.0
Adult ADHD Shared Care – March 2021
Children’s ADHD Shared care June 2021
Antipyschotic Leaflet September 2019 v2.0
Dexamfetamine for Narcolepsy SCG v1.0
APC position statement non-palliative care use of opiates
Sativex MS SCG Sept 2020 v1.0
Apomorphine shared care agreement V1.0

Headache Management Guidelines (Adult) – May 2016 Northern East Update, endorsed for use in North of Tyne and Gateshead areas – CURRENTLY UNDER REVIEW
Ketamine-in-Palliative-Care-pain-2020 v1.0
Lithium-shared-care-update June 2019 v2.0
Melatonin – Shared Care June 2021
Vigabatrin SCG – Jul 2014

Infections and antibiotics
Nice Antimicrobial Guidance
Nebulised – Gentamicin Information-for-Primary-Care v2.0

Endocrine System
Denosumab Information leaflet 2018
Thyroid Gudelines (TRAMP2) June 2018
Osteoporosis guidelines, including bisphosphonate review Dec 17
Liothyronine prescribing guidance v0.4
Gender dysphoria hormone regional guidance

Genito-Urinary System
Erectile Dysfunction – Guidelines for the investigation and management of men with ED – Updated Sep 2015 – CURRENTLY UNDER REVIEW
Non Surgical Management of Overactive Bladder (OAB) Pathway February 2021
Urology Guideline – March 19
Methylphenidate for giggle incontinence – Children – July 2018
Catheter Formulary and guidance v2.0
Catheter info sheet v1.0

Renal Disease
Renal Patients – Symptom Management v1.0

Malignant Disease and Immunosuppression
Guidelines for the Monitoring of Immune Modifying Drugs (IMDs) in Stable Adult Patients (excluding post transplantation in Primary and Secondary Care – July 2018
Immunosuppressive-treatment-following-liver-transplants-SCG June 21
Immunosuppression following Paediatric renal transplantation SCG – Oct 17
Immunosuppressive Treatment following Renal Transplant – Dec 2016
Lanreotide and Octreotide July 2019 v2.0
Immunosuppressive-Treatment-for-Paediatric-Nephrotic-Syndrome-SCG July 2020 v1.0
Tocilizumab-monitoring-shared-care-guidance-June-18 v1
NECN Palliative and End of Life Care guidelines 2016

Nutrition and Blood
Erythropoietin (Darbepoetin [Aranesp]) in the Treatment of Patients with CKD – Jul 17
Cinacalcet in primary hyperparathyroidism – 2020 final V4
Cows-milk-allergy-and-lactose-intolerance-guidance-January-2021 V3
Vitamin D Quick reference guide v3.0
Vitamin B12 management v1.1
Gluten Free guidance Dec 18 (v2.1
Oral Nutritional Support guidance and formulary FINAL v1.0 Jan 2021
Preterm Infant feeding prescribing guideline 2021-final
Faltering Growth February 2021 final

Musculoskeletal and Joint Diseases

Ear, Eyes, Nose and Throat
ENT Guideline – Feb 2017
Eye conditions – NoT & G Guidelines for the management of common Opthalmology Conditions – Sep 2016

Acne management Guidelines v2.1

Blood-glucose-monitoring-guideline v2.0
Diabetes Stepped Approach guideline Jan 2019

Other Guidance
Brand name prescribing v 1.0 update
Prescribing Intervals Guidance July 2021
Seven-day-Rx-and-Monitored-dosage-systems Jan 2019
Stoma-Prescribing-Guidelines Sept 2020
Swallowing-difficulties v2.0
Third party ordering – January 2019 (expiry date extension)